Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$43.93 - $46.76 $147,604 - $157,113
3,360 Added 23.36%
17,745 $799,000
Q1 2023

May 12, 2023

SELL
$45.29 - $50.76 $79,212 - $88,779
-1,749 Reduced 10.84%
14,385 $660,000
Q4 2022

Feb 13, 2023

BUY
$41.91 - $50.48 $676,175 - $814,444
16,134 New
16,134 $804,000
Q2 2022

Aug 04, 2022

SELL
$42.98 - $49.77 $280,315 - $324,599
-6,522 Closed
0 $0
Q1 2022

May 11, 2022

SELL
$42.23 - $54.3 $447,300 - $575,145
-10,592 Reduced 61.89%
6,522 $320,000
Q4 2021

Feb 14, 2022

BUY
$50.62 - $56.47 $511,262 - $570,347
10,100 Added 144.0%
17,114 $951,000
Q3 2021

Nov 15, 2021

BUY
$46.55 - $56.83 $12,196 - $14,889
262 Added 3.88%
7,014 $362,000
Q2 2021

Aug 13, 2021

BUY
$46.28 - $52.75 $312,482 - $356,168
6,752 New
6,752 $327,000
Q3 2020

Nov 16, 2020

SELL
$42.51 - $52.42 $306,072 - $377,424
-7,200 Closed
0 $0
Q2 2020

Aug 06, 2020

BUY
$39.49 - $44.36 $284,328 - $319,392
7,200 New
7,200 $308,000
Q3 2019

Nov 14, 2019

SELL
$32.73 - $40.81 $1.46 Million - $1.82 Million
-44,615 Closed
0 $0
Q2 2019

Aug 12, 2019

BUY
$35.73 - $41.39 $1.59 Million - $1.85 Million
44,615 New
44,615 $1.81 Million
Q4 2018

Feb 14, 2019

SELL
$32.65 - $37.95 $424,939 - $493,919
-13,015 Closed
0 $0
Q3 2018

Oct 18, 2018

BUY
$35.99 - $39.39 $468,409 - $512,660
13,015 New
13,015 $493,000
Q2 2018

Aug 07, 2018

SELL
$31.23 - $37.47 $3.37 Million - $4.04 Million
-107,800 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$31.01 - $34.72 $3.34 Million - $3.74 Million
107,800 New
107,800 $3.48 Million
Q4 2017

Feb 12, 2018

SELL
$30.68 - $35.37 $1.34 Million - $1.55 Million
-43,700 Closed
0 $0
Q3 2017

Oct 16, 2017

BUY
$31.02 - $32.94 $1.11 Million - $1.18 Million
35,900 Added 460.26%
43,700 $1.38 Million
Q2 2017

Aug 10, 2017

BUY
N/A
7,800
7,800 $262,000

Others Institutions Holding QGEN

About QIAGEN N.V.


  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $9.24B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track This Portfolio

Track Seven Eight Capital, LP Portfolio

Follow Seven Eight Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.